---
id: ventriculitis-ependymal-enhancement_158
category: radiology
tags: [ventriculitis, ependymal-enhancement, intraventricular-infection, MRI, CNS-infection]
deck: Infectious Diseases
created: 2025-11-11
modified: 2025-11-11
---

## Ventriculitis - Ependymal Enhancement

**Q:** What is ventriculitis, what are its characteristic MRI findings including ependymal enhancement, and why does it have such high mortality?

**A:**

## DEFINITION

**Ventriculitis:** **"Infection/inflammation of the ventricular system (ependymal lining and CSF within ventricles)"**

**MRI Hallmark:** **Ependymal enhancement + intraventricular debris/septations**

**Key Point:** **Ventriculitis = life-threatening complication** (50-80% mortality)

---

## PATHOPHYSIOLOGY

**Routes of Infection:**

**Mnemonic: "RUPTURE-SHUNT-MENINGITIS"**

**R**upture of brain abscess into ventricle (most common route)
**U**nderlying meningitis (extension)
**P**enetrating trauma (ventricular entry)
**T**hrombophlebitis (septic)
**U**nderlying infection (brain abscess)
**R**etrograde spread (from meninges)
**E**xtension from adjacent abscess

**S**hunt infection (VP shunt, external ventricular drain)
**H**ematogenous (septic emboli - rare)
**U**pward spread (meningitis → ventriculitis)
**N**eurosurgery (post-operative)
**T**rauma (penetrating head injury)

**M**eningitis complication (extension into ventricles)
**E**VD (external ventricular drain - iatrogenic)
**N**eonates (neonatal meningitis → ventriculitis)
**I**atrogenic (shunt, EVD, post-operative)
**N**eurosurgical procedures
**G**rowing from abscess rupture
**I**nfection spreading
**T**ransmural (abscess → ventricle)
**I**ntraventricular seeding
**S**howing intraventricular debris

**Key Point:** **Brain abscess rupture into ventricle = most common cause** (30-50% mortality → 80%)

---

## MRI FINDINGS

**Hallmark: Ependymal Enhancement + Intraventricular Debris**

### **Mnemonic: "VENTRICLE-DEBRIS"**

**V**entricular enhancement (ependymal lining)
**E**pendyma enhanced (smooth, linear)
**N**ormal ependyma doesn't enhance
**T**hin, smooth enhancement (ventricular walls)
**R**estricted diffusion (intraventricular pus/debris)
**I**ntraventricular debris (echogenic on ultrasound, T1 hyperintense)
**C**horoid plexus enhancement (may be prominent)
**L**ining of ventricles bright (post-contrast)
**E**nlarged ventricles (hydrocephalus)

**D**ebris (intraventricular - pus, inflammatory exudate)
**E**pendymal lining enhanced (pathologic)
**B**right on FLAIR (intraventricular fluid hyperintense)
**R**estricted diffusion (DWI bright, ADC dark - purulent debris)
**I**ntraventricular septations (loculated ventricles)
**S**eptations may form (compartmentalize ventricles)

**Key Point:** **Ependymal enhancement + intraventricular debris = ventriculitis**

---

## MRI SEQUENCES

### **Post-Contrast T1:**
- **Ependymal enhancement** (smooth, thin, linear - ventricular walls)
- **Choroid plexus enhancement** (may be prominent, but normally enhances)
- **Intraventricular septations** enhance (if loculated)

**Key Point:** **Abnormal ependymal enhancement = ventriculitis** (normally ependyma doesn't enhance)

---

### **FLAIR:**
- **Intraventricular hyperintensity** (debris, pus, protein)
- **Normal:** Ventricles are "black" (CSF dark on FLAIR)
- **Abnormal:** Bright signal in ventricles (inflammatory exudate)

**Key Point:** **FLAIR hyperintensity in ventricles = debris/pus**

---

### **DWI/ADC:**
- **DWI hyperintense** (bright - restricted diffusion)
- **ADC hypointense** (dark - low ADC)
- **Purulent debris restricts** (confirms infectious nature)

**Key Point:** **Restricted diffusion in ventricles = purulent ventriculitis**

---

### **T1 Pre-Contrast:**
- **Intraventricular debris** may be **hyperintense** (proteinaceous, hemorrhagic)
- **Layering debris** in dependent portions

---

## VENTRICULITIS vs NORMAL VARIANTS

**Normal Findings (Don't Confuse):**
- **Choroid plexus normally enhances** (highly vascular)
- **Minimal ependymal enhancement** can be normal (especially in infants)

**Abnormal (Ventriculitis):**
- **Diffuse smooth ependymal enhancement** (all ventricular walls)
- **Intraventricular debris** (FLAIR bright, restricted diffusion)
- **Septations** (loculated ventricles)
- **Clinical context** (fever, altered mental status, recent neurosurgery)

**Key Point:** **Diffuse ependymal enhancement + debris + clinical context = ventriculitis**

---

## SHUNT INFECTION vs VENTRICULITIS

**VP Shunt Infection:**
- **Colonization** of shunt hardware (biofilm)
- **May NOT have ventriculitis** (infection confined to shunt)
- **Diagnosis:** Shunt tap (CSF analysis)

**Ventriculitis (with or without shunt):**
- **Infection of ventricular system** (ependyma + intraventricular CSF)
- **Imaging abnormalities** (ependymal enhancement, debris)
- **More severe** (higher mortality)

**Key Point:** **Shunt infection ≠ ventriculitis** (but ventriculitis can occur with shunt infection)

---

## CLINICAL PRESENTATION

**Symptoms:**
- **Altered mental status** (confusion, lethargy, coma)
- **Fever** (60-80%)
- **Headache** (60-80%)
- **Nausea/vomiting** (increased ICP)
- **Meningismus** (stiff neck - if concurrent meningitis)
- **Seizures** (20-30%)

**Signs:**
- **Decreased consciousness** (GCS <11 common)
- **Hydrocephalus** (obstructive or communicating)
- **Signs of increased ICP** (papilledema, Cushing's triad)

**Key Point:** **Altered mental status = most common presenting symptom**

---

## CSF FINDINGS

**Ventricular CSF:**
- **WBC:** >1000 cells/μL (PMN predominant)
- **Protein:** >200 mg/dL (markedly elevated)
- **Glucose:** <20 mg/dL (very low)
- **Gram stain:** Positive in 50-70%
- **Culture:** Positive in 70-85%

**Key Point:** **Very low glucose (<20) = poor prognostic sign**

---

## ORGANISMS

**Mnemonic: "STAPH-GRAM-NEG-STREP"**

**Shunt-Related:**
- ***Staphylococcus epidermidis*** (coagulase-negative staph - most common, 50-60%)
- ***Staphylococcus aureus*** (MRSA, 20-30%)
- **Propionibacterium** (Cutibacterium acnes - skin flora)

**Post-Neurosurgery:**
- ***Staphylococcus aureus*** (MRSA)
- **Gram-negatives** (Pseudomonas, Enterobacter, Klebsiella)

**From Meningitis/Abscess Rupture:**
- ***Streptococcus*** species (S. pneumoniae, S. milleri group)
- **Anaerobes** (if abscess rupture)
- **Gram-negatives** (E. coli, Klebsiella - neonates)

**Key Point:** **Coag-negative Staph = most common** (shunt-related)

---

## DIAGNOSIS

**Imaging:**
- **MRI with contrast + DWI** (diagnostic)
- **CT** (less sensitive, but shows hydrocephalus)

**CSF Analysis:**
- **Ventricular tap** (if EVD in place or via LP if communicating)
- **Cell count, protein, glucose, Gram stain, culture**

**Blood Cultures:** Positive in 30-40%

**Key Point:** **MRI with DWI + ventricular CSF = diagnostic**

---

## TREATMENT

**Emergent Neurosurgical Consultation:**

### **Surgical:**
- **External ventricular drain (EVD)** placement (drain infected CSF, monitor ICP)
- **Remove infected shunt** (if shunt-associated)
- **Drain any associated abscess** (if abscess rupture into ventricle)
- **Intraventricular antibiotics** (controversial, case-by-case)

### **Medical:**

**Empiric IV Antibiotics (Until cultures):**
- **Vancomycin** 15-20 mg/kg IV q8-12h + **Cefepime** 2g IV q8h OR **Meropenem** 2g IV q8h
- **Covers:** MRSA, Gram-negatives, Pseudomonas

**Targeted (Based on cultures):**
- **MRSA:** Vancomycin or linezolid
- **Gram-negatives:** Cefepime, meropenem, or ceftazidime
- **Pseudomonas:** Cefepime or meropenem + aminoglycoside (consider)

**Duration:** 3-4 weeks IV (minimum)

**Intraventricular Antibiotics (Controversial):**
- **Vancomycin** 10-20mg/day OR **Gentamicin** 5-10mg/day (via EVD)
- **Consider if:** Persistent positive cultures, difficult-to-treat organisms, clinical failure

**Key Point:** **EVD + IV antibiotics + remove shunt (if present) = essential**

---

## COMPLICATIONS

**Mnemonic: "HYDROCE PHALUS-DEATH"**

**H**ydrocephalus (obstructive - septations, debris)
**Y**ielding poor outcome (high mortality)
**D**ecreased consciousness (coma)
**R**efractory seizures
**O**bstructive hydrocephalus (requires EVD)
**C**ommunicating hydrocephalus (late)
**E**pendymal scarring (chronic)

**P**ermanent neurologic deficit (50-70% of survivors)
**H**erniation (if hydrocephalus untreated)
**A**bscess formation (brain parenchymal)
**L**ong-term shunt dependence (50-70%)
**U**ncontrolled infection (persistent)
**S**epsis (systemic)

**D**eath (50-80% mortality)
**E**epilepsy (chronic seizures)
**A**bscess recurrence
**T**rauma from procedures (hemorrhage)
**H**ydrocephalus requiring permanent shunt

**Key Point:** **Hydrocephalus most common complication** (obstructive from debris/septations)

---

## PROGNOSIS

**Mortality:** 50-80% (even with treatment)

**Factors Predicting Poor Outcome:**
1. **Abscess rupture into ventricle** (vs shunt infection) - 80% mortality
2. **Coma at presentation** (GCS <8)
3. **Gram-negative organisms** (worse than Gram-positive)
4. **Delayed diagnosis** (>48 hours)
5. **Intraventricular septations** (loculated ventricles)
6. **Very low CSF glucose** (<10 mg/dL)
7. **Age extremes** (neonates, elderly)

**Survivors:**
- **Full recovery:** 10-20%
- **Neurologic sequelae:** 50-70% (cognitive deficits, seizures, hydrocephalus)
- **Permanent shunt dependence:** 50-70%

**Key Point:** **Abscess rupture into ventricle = 80% mortality** (vs 20-30% abscess alone)

---

## PREVENTION

**Shunt Infection Prevention:**
- **Sterile technique** (shunt placement)
- **Antibiotic prophylaxis** (peri-operative)
- **Minimize shunt revisions**

**EVD-Related Ventriculitis:**
- **Sterile insertion**
- **Minimize duration** (<5-7 days if possible)
- **Antibiotic-impregnated catheters** (reduce infection risk)

**Key Point:** **EVD duration <7 days** reduces ventriculitis risk

---

**Clinical Pearls:**
- **Ventriculitis = infection of ventricular system** (ependyma + intraventricular CSF)
- **Ependymal enhancement + intraventricular debris = ventriculitis**
- **Restricted diffusion in ventricles (DWI bright, ADC dark) = purulent debris**
- **Brain abscess rupture into ventricle = #1 cause** (mortality 30% → 80%)
- **Coag-negative Staph = most common** (shunt-related)
- **Mortality 50-80%** (even with treatment)
- **Treatment: EVD + IV antibiotics + remove shunt** (if present)
- **Intraventricular antibiotics controversial** (case-by-case)
- **Hydrocephalus most common complication** (obstructive)
- **Survivors: 50-70% have permanent neurologic sequelae**
- **Prevention: Sterile technique, EVD duration <7 days**

**Media:**

**Additional Resources:**
- **Radiopaedia.org:** Search "ventriculitis," "ependymal enhancement"
- **Neurosurgery:** Ventriculitis management
- **PMC:** Ventriculitis outcomes

**Sources:** [Radiopaedia - Ventriculitis], [Neurosurgery - Ventriculitis Management], [IDSA CNS Infection Guidelines]
